Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Samsung Biologics to acquire PolyPeptide in $1.81bn cash deal
Samsung Biologics is set to acquire PolyPeptide Group through an all-cash public tender offer valued at SFr1.46bn ($1.81bn).
Contract Manufacturers
-
20 Jul 2026
-
03 May 2022
Intravac signs licensing deal with Zhifei Lvzhu for whooping cough vaccine
Intravacc has signed an exclusive licensing agreement with Beijing Zhifei Lvzhu Biopharmaceutical (Zhifei Lvzhu) in China for Avacc 3, an OMV-based whooping cough vaccine.
-
28 Jan 2021
Sanofi to manufacture 125 million doses of Pfizer-BioNTech’s Covid-19 vaccine
French pharma giant Sanofi has entered into an agreement with BioNTech, to manufacture the Covid-19 vaccine co-developed by BioNTech and Pfizer.
-
18 Jan 2021
Thermo Fisher Scientific acquires viral vector business from Novasep for $875m
Thermo Fisher Scientific announced the acquisition of Henogen, a Belgian viral vector manufacturing business belonging to Groupe Novasep, for about €725m ($875m) in cash.